Pancreatic Cancer
- Other Endocrine System, PancreasRandomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine TumorsPrincipal Investigator: Pamela L. Kunz
- Colon, Esophagus, Liver, PancreasAn Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Multiple Solid TumorsPrincipal Investigator: Michael Cecchini
- PancreasA Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic CancerPrincipal Investigator: John Kunstman
- PancreasComparing the Clinical Impact of Pancreatic Cyst Surveillance ProgramsPrincipal Investigator: James Farrell
- PancreasPhase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic AdenocarcinomaPrincipal Investigator: Kimberly L. Johung